These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25269682)

  • 1. Ferumoxytol-enhanced magnetic resonance angiography is a feasible method for the clinical evaluation of lower extremity arterial disease.
    Walker JP; Nosova E; Sigovan M; Rapp J; Grenon MS; Owens CD; Gasper WJ; Saloner DA
    Ann Vasc Surg; 2015 Jan; 29(1):63-8. PubMed ID: 25269682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of three-dimensional magnetic resonance angiography-fluoroscopy image fusion technique in guiding complex endovascular aortic procedures in patients with renal insufficiency.
    Schwein A; Chinnadurai P; Shah DJ; Lumsden AB; Bechara CF; Bismuth J
    J Vasc Surg; 2017 May; 65(5):1440-1452. PubMed ID: 28017584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of non-contrast enhanced quiescent interval single shot (QISS) magnetic resonance angiography at 3T for lower extremity peripheral arterial disease, in comparison to CT angiography.
    Wu G; Yang J; Zhang T; Morelli JN; Giri S; Li X; Tang W
    J Cardiovasc Magn Reson; 2016 Oct; 18(1):71. PubMed ID: 27760564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermodality feature fusion combining unenhanced computed tomography and ferumoxytol-enhanced magnetic resonance angiography for patient-specific vascular mapping in renal impairment.
    Yoshida T; Nguyen KL; Shahrouki P; Quinones-Baldrich WJ; Lawrence PF; Finn JP
    J Vasc Surg; 2020 May; 71(5):1674-1684. PubMed ID: 31734117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial imaging in patients with lower extremity ischemia and diabetes mellitus.
    Pomposelli F
    J Vasc Surg; 2010 Sep; 52(3 Suppl):81S-91S. PubMed ID: 20804938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Noncontrast Quiescent-Interval Single-Shot Lower Extremity MR Angiography Versus CT Angiography for Diagnosis of Peripheral Artery Disease: Comparison With Digital Subtraction Angiography.
    Varga-Szemes A; Wichmann JL; Schoepf UJ; Suranyi P; De Cecco CN; Muscogiuri G; Caruso D; Yamada RT; Litwin SE; Tesche C; Duguay TM; Giri S; Vliegenthart R; Todoran TM
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1116-1124. PubMed ID: 28109932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Quiescent-Interval Single-Shot Magnetic Resonance Angiography in Diabetic Patients With Critical Limb Ischemia Undergoing Digital Subtraction Angiography: Comparison With Contrast-Enhanced Magnetic Resonance Angiography With Calf Compression at 3.0 Tesla.
    Wei LM; Zhu YQ; Zhang PL; Lu HT; Zhao JG
    J Endovasc Ther; 2019 Feb; 26(1):44-53. PubMed ID: 30580695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent.
    Li W; Tutton S; Vu AT; Pierchala L; Li BS; Lewis JM; Prasad PV; Edelman RR
    J Magn Reson Imaging; 2005 Jan; 21(1):46-52. PubMed ID: 15611942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body MR angiography in patients with peripheral arterial disease.
    Nielsen YJ
    Dan Med Bull; 2010 Dec; 57(12):B4231. PubMed ID: 21122468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of contrast-enhanced multi-station MR angiography and digital subtraction angiography of the lower extremity arterial disease.
    Burbelko M; Augsten M; Kalinowski MO; Heverhagen JT
    J Magn Reson Imaging; 2013 Jun; 37(6):1427-35. PubMed ID: 23188773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating peripheral arterial disease with unenhanced quiescent-interval single-shot MR angiography at 3 T.
    Amin P; Collins JD; Koktzoglou I; Molvar C; Markl M; Edelman RR; Carr JC
    AJR Am J Roentgenol; 2014 Apr; 202(4):886-93. PubMed ID: 24660721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease.
    Stoumpos S; Hennessy M; Vesey AT; Radjenovic A; Kasthuri R; Kingsmore DB; Mark PB; Roditi G
    Eur Radiol; 2019 Jul; 29(7):3543-3552. PubMed ID: 30919067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort.
    Nayak AB; Luhar A; Hanudel M; Gales B; Hall TR; Finn JP; Salusky IB; Zaritsky J
    Pediatr Nephrol; 2015 Mar; 30(3):515-21. PubMed ID: 25212105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol.
    Luhar A; Khan S; Finn JP; Ghahremani S; Griggs R; Zaritsky J; Salusky I; Hall TR
    Pediatr Radiol; 2016 Aug; 46(9):1332-40. PubMed ID: 27059620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-observer comparison study between unenhanced quiescent-interval single-shot magnetic resonance angiography and invasive carbon dioxide angiography in patients with peripheral arterial disease and chronic renal insufficiency.
    Arendt CT; Leithner D; Lenga L; Wichmann JL; Albrecht MH; Czwikla R; Varga-Szemes A; d'Angelo T; Martin SS; Thalhammer A; Nagel E; Vogl TJ; Gruber-Rouh T
    Eur J Radiol; 2018 Nov; 108():140-146. PubMed ID: 30396647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion.
    Shahrouki P; Moriarty JM; Khan SN; Bista B; Kee ST; DeRubertis BG; Yoshida T; Nguyen KL; Finn JP
    J Cardiovasc Magn Reson; 2019 Mar; 21(1):17. PubMed ID: 30853026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-gadolinium-enhanced 3-dimensional magnetic resonance angiography for the evaluation of thoracic aortic disease: a preliminary experience.
    Srichai MB; Kim S; Axel L; Babb J; Hecht EM
    Tex Heart Inst J; 2010; 37(1):58-65. PubMed ID: 20200628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced 3D MRA with centric ordering in k space: a preliminary clinical experience in imaging the abdominal aorta and renal and peripheral arterial vasculature.
    Shetty AN; Bis KG; Vrachliotis TG; Kirsch M; Shirkhoda A; Ellwood R
    J Magn Reson Imaging; 1998; 8(3):603-15. PubMed ID: 9626875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular Imaging With Ferumoxytol as a Contrast Agent.
    Hope MD; Hope TA; Zhu C; Faraji F; Haraldsson H; Ordovas KG; Saloner D
    AJR Am J Roentgenol; 2015 Sep; 205(3):W366-73. PubMed ID: 26102308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D non-contrast-enhanced ECG-gated MR angiography of the lower extremities with dual-source radiofrequency transmission at 3.0 T: Intraindividual comparison with contrast-enhanced MR angiography in PAOD patients.
    Rasper M; Wildgruber M; Settles M; Eckstein HH; Zimmermann A; Reeps C; Rummeny EJ; Huber AM
    Eur Radiol; 2016 Sep; 26(9):2871-80. PubMed ID: 26560724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.